Company Synvista Therapeutics, Inc. Nasdaq
Equities
SYNI
US87164M1009
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% |
|
-.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Noah Berkowitz
CEO | Chief Executive Officer | 60 | 06-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 10,000,000 | 0 | 0 | 15.89 % |
Stock B | 1 | 2,586,326 | 2,000,000 ( 77.33 %) | 0 |
Company contact information
Synvista Therapeutics, Inc.
6 Campus Drive
07054, Parsippany
+
![address Synvista Therapeutics, Inc.(SYNI)](https://cdn.zonebourse.com/static/address/5153183.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+48.07% | 57.87B | |
+41.65% | 40.25B | |
-7.02% | 39.94B | |
-5.96% | 28.54B | |
+12.14% | 26.4B | |
-20.70% | 19.33B | |
+30.11% | 12.4B | |
-0.82% | 12.23B | |
+24.43% | 12.2B |
- Stock Market
- Equities
- SYNI Stock
- SYNI Stock
- Company Synvista Therapeutics, Inc.